Linda Palczuk is Director of AVADEL PHARMACEUTICALS PLC. Currently has a direct ownership of 63,400 shares of AVDL, which is worth approximately $711,348. The most recent transaction as insider was on Jul 30, 2024, when has been sold 11,000 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 63.4K
0% 3M change
20.99% 12M change
Total Value Held $711,348

Linda Palczuk Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 30 2024
BUY
Grant, award, or other acquisition
-
11,000 Added 14.78%
63,400 Ordinary Shares
May 09 2023
BUY
Open market or private purchase
$36,900 $14.76 p/Share
2,500 Added 4.55%
52,400 ADSs
Dec 23 2022
BUY
Open market or private purchase
$14,400 $7.2 p/Share
2,000 Added 3.85%
49,900 ADSs
May 27 2022
BUY
Open market or private purchase
$16,000 $1.6 p/Share
10,000 Added 17.27%
47,900 ADSs
LP

Linda Palczuk

Director
Dublin 2, L2

Track Institutional and Insider Activities on AVDL

Follow AVADEL PHARMACEUTICALS PLC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVDL shares.

Notify only if

Insider Trading

Get notified when an Avadel Pharmaceuticals PLC insider buys or sells AVDL shares.

Notify only if

News

Receive news related to AVADEL PHARMACEUTICALS PLC

Track Activities on AVDL